Clinical Trial Update: Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sequential versus upfront intensified neoadjuvant chemotherapy for large resectable or locally advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Radboud University Medical Center | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED